BMRN) recently. EVP George Eric Davis sold 9,844 shares at an average price of $96.60 on June 23rd. Davis now owns $8,073,925 of stock as recorded in a recent Form 4 SEC filing. Sr VP Brian Mueller disclosed the sale of 2,671 shares …
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple …
The stock of BioMarin Pharmaceutical Inc. See BioMarin Pharmaceutical Inc. About 285,045 shares traded. LivePerson, Inc. (LPSN) has risen 55.95% since …
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Reviewed By Analysts Stock market analysts watching BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) have recently changed their... Bank Of Marin Bancorp (BMRC) Reviewed By …
Quantum Capital Management increased its stake in Biomarin Pharmaceutical …
The stock of Cytokinetics, Inc. The firm has "Buy" rating by Liberum Capital given …
BioMarin Pharmaceutical Inc. (BMRN) Downgraded by BidaskClub In other …
This suggests that analysts have very recently bumped up their estimates for BMRN, giving the stock a Zacks Earnings ESP of +4.55% heading into earnings season. BioMarin Pharmaceutical Inc. Price and EPS Surprise | BioMarin
The Notes will be convertible into shares of BioMarin's common stock plus, if applicable, cash in lieu of any fractional …